2-aminopurine has been researched along with Hormone-Dependent Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, B; Mohapatra, S; Pledger, WJ; Zhao, X | 1 |
| Osborne, MP; Tiwari, RK | 1 |
2 other study(ies) available for 2-aminopurine and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells.
Topics: 2-Aminopurine; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Cyclin-Dependent Kinases; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Protein Kinase Inhibitors; Proteins; Purines; Roscovitine; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein | 2005 |
A distinct kinase modulates the expression of IFN-inducible genes in human breast cancer cells.
Topics: 2-Aminopurine; Breast Neoplasms; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Interferon Type I; Interferons; Neoplasms, Hormone-Dependent; Oncogene Proteins, Viral; Phosphotransferases; Receptor, ErbB-2; Tamoxifen; Transcriptional Activation; Tumor Cells, Cultured | 1991 |